What's Happening?
Galderma has introduced ALASTIN Signature Practices, a new initiative aimed at integrating regenerative skincare into dermatology and aesthetic practices across the U.S. This program recognizes clinics that consistently incorporate ALASTIN's skincare products
into their patient care, offering a comprehensive range of products for procedural and daily skincare. The first ALASTIN Signature Practice has been established at the Colorado Springs Dermatology Clinic, with plans to expand to other key markets throughout 2026. This initiative underscores Galderma's commitment to advancing dermatological care through innovative, science-based skincare solutions.
Why It's Important?
The launch of ALASTIN Signature Practices represents a significant advancement in the field of dermatology and aesthetic medicine. By promoting the integration of regenerative skincare into clinical practices, Galderma is enhancing the quality of patient care and outcomes. This initiative supports medical professionals in providing comprehensive skincare solutions, which can lead to improved patient satisfaction and loyalty. Additionally, it positions Galderma as a leader in the dermatology market, potentially increasing its market share and influence in the rapidly growing skincare industry.
What's Next?
Galderma plans to expand the ALASTIN Signature Practices program to additional markets across the U.S. in 2026. This expansion will involve further collaboration with dermatology and aesthetic clinics to integrate ALASTIN's skincare products into their treatment regimens. The program will also include ongoing education and support for participating practices, ensuring they remain at the forefront of skincare innovation. As more clinics join the program, it is expected to drive broader adoption of regenerative skincare practices, benefiting both patients and healthcare providers.
